AbbVie Inc. (abbv)
ABBV News
Live headlines and press releases for AbbVie Inc. load in the terminal.
Company news & press releases is available in Vest Terminal for Professional and Enterprise subscribers.
AbbVie Inc. FAQ
What does AbbVie Inc. (ABBV) do?
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruv…
What is ABBV's P/E ratio?
AbbVie Inc. has a trailing P/E of 69.48× based on publicly available market data.
Does ABBV pay a dividend?
Indicated dividend yield: 2.8%. Confirm ex-dates and payout history in Vest Terminal.
What sector is ABBV in?
AbbVie Inc. is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is ABBV's market capitalization?
Approximate market cap: $430.95B.
What are the main risks for ABBV?
Key risks include elevated valuation, among factors on this page.
What are the strengths of ABBV?
Potential positives include revenue growth of 10.2% year-over-year, earnings growth of 2.9% year-over-year.
Where can I get analyst estimates for ABBV?
Consensus estimates, price targets, and detailed analyst data for AbbVie Inc. are available to Professional subscribers in Vest Terminal — not on this public summary page.